# Tennant Co: financial statements, quarterly

TNC · NYSE · CIK 97134 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tnc.md) · [Financials](/companies/tnc/financials.md) · [Filings](/companies/tnc/filings.md) · [Insiders](/companies/tnc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tnc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [305](/filings/0000097134-24-000037.md) | [311 d](/filings/0000097134-26-000008.md) | [311](/filings/0000097134-25-000014.md) | [331](/filings/0000097134-25-000027.md) | [316](/filings/0000097134-25-000036.md) | [329 d](/filings/0000097134-26-000008.md) | [290](/filings/0000097134-26-000015.md) | [319](/filings/0000097134-26-000024.md) | [303](/filings/0000097134-25-000036.md) | [292 d](/filings/0000097134-26-000008.md) | [298](/filings/0000097134-26-000015.md) | [324](/filings/0000097134-26-000024.md) |
| Cost of revenue | $m | [173](/filings/0000097134-24-000037.md) | [181 d](/filings/0000097134-26-000008.md) | [174](/filings/0000097134-25-000014.md) | [188](/filings/0000097134-25-000027.md) | [182](/filings/0000097134-25-000036.md) | [193 d](/filings/0000097134-26-000008.md) | [170](/filings/0000097134-26-000015.md) | [185](/filings/0000097134-26-000024.md) | [174](/filings/0000097134-25-000036.md) | [191 d](/filings/0000097134-26-000008.md) | [184](/filings/0000097134-26-000015.md) | [196](/filings/0000097134-26-000024.md) |
| Gross profit | $m | [132](/filings/0000097134-24-000037.md) | [131 d](/filings/0000097134-26-000008.md) | [138](/filings/0000097134-25-000014.md) | [143](/filings/0000097134-25-000027.md) | [134](/filings/0000097134-25-000036.md) | [136 d](/filings/0000097134-26-000008.md) | [120](/filings/0000097134-26-000015.md) | [134](/filings/0000097134-26-000024.md) | [129](/filings/0000097134-25-000036.md) | [101 d](/filings/0000097134-26-000008.md) | [114](/filings/0000097134-26-000015.md) | [128](/filings/0000097134-26-000024.md) |
| Research and development | $m | [9.1](/filings/0000097134-24-000037.md) | [10.6 d](/filings/0000097134-26-000008.md) | [10.1](/filings/0000097134-25-000014.md) | [11.2](/filings/0000097134-25-000027.md) | [10.5](/filings/0000097134-25-000036.md) | [12.0 d](/filings/0000097134-26-000008.md) | [9.7](/filings/0000097134-26-000015.md) | [9.8](/filings/0000097134-26-000024.md) | [10.5](/filings/0000097134-25-000036.md) | [11.2 d](/filings/0000097134-26-000008.md) | [10.6](/filings/0000097134-26-000015.md) | [12.5](/filings/0000097134-26-000024.md) |
| Selling, general and administrative | $m | [88.2](/filings/0000097134-24-000037.md) | [95.7 d](/filings/0000097134-26-000008.md) | [89.9](/filings/0000097134-25-000014.md) | [92.9](/filings/0000097134-25-000027.md) | [92.7](/filings/0000097134-25-000036.md) | [116 d](/filings/0000097134-26-000008.md) | [90.7](/filings/0000097134-26-000015.md) | [93.7](/filings/0000097134-26-000024.md) | [96.6](/filings/0000097134-25-000036.md) | [93.8 d](/filings/0000097134-26-000008.md) | [98.1](/filings/0000097134-26-000015.md) | [99.5](/filings/0000097134-26-000024.md) |
| Operating income | $m | [34.7](/filings/0000097134-24-000037.md) | [24.5 d](/filings/0000097134-26-000008.md) | [37.5](/filings/0000097134-25-000014.md) | [38.6](/filings/0000097134-25-000027.md) | [30.6](/filings/0000097134-25-000036.md) | [7.6 d](/filings/0000097134-26-000008.md) | [19.6](/filings/0000097134-26-000015.md) | [30.6](/filings/0000097134-26-000024.md) | [22.3](/filings/0000097134-25-000036.md) | [(4.2) d](/filings/0000097134-26-000008.md) | [4.9](/filings/0000097134-26-000015.md) | [15.9](/filings/0000097134-26-000024.md) |
| Interest expense | $m | [3.3](/filings/0000097134-24-000037.md) | not reported | [2.3](/filings/0000097134-25-000014.md) | [2.5](/filings/0000097134-25-000027.md) | [2.7](/filings/0000097134-25-000036.md) | not reported | [2.3](/filings/0000097134-26-000015.md) | [2.2](/filings/0000097134-26-000024.md) | [2.4](/filings/0000097134-25-000036.md) | not reported | [3.4](/filings/0000097134-26-000015.md) | [4.3](/filings/0000097134-26-000024.md) |
| Income tax | $m | [7.0](/filings/0000097134-24-000037.md) | [(9.0) d](/filings/0000097134-26-000008.md) | [6.7](/filings/0000097134-25-000014.md) | [9.0](/filings/0000097134-25-000027.md) | [6.7](/filings/0000097134-25-000036.md) | [(1.3) d](/filings/0000097134-26-000008.md) | [4.1](/filings/0000097134-26-000015.md) | [7.1](/filings/0000097134-26-000024.md) | [4.5](/filings/0000097134-25-000036.md) | [(1.6) d](/filings/0000097134-26-000008.md) | [0.7](/filings/0000097134-26-000015.md) | [2.7](/filings/0000097134-26-000024.md) |
| Net income | $m | [22.9](/filings/0000097134-24-000037.md) | [31.0 d](/filings/0000097134-26-000008.md) | [28.4](/filings/0000097134-25-000014.md) | [27.9](/filings/0000097134-25-000027.md) | [20.8](/filings/0000097134-25-000036.md) | [6.6 d](/filings/0000097134-26-000008.md) | [13.1](/filings/0000097134-26-000015.md) | [20.2](/filings/0000097134-26-000024.md) | [14.9](/filings/0000097134-25-000036.md) | [(4.4) d](/filings/0000097134-26-000008.md) | [0.2](/filings/0000097134-26-000015.md) | [7.6](/filings/0000097134-26-000024.md) |
| Diluted EPS | $ per share | [1.21](/filings/0000097134-24-000037.md) | not reported | [1.49](/filings/0000097134-25-000014.md) | [1.45](/filings/0000097134-25-000027.md) | [1.09](/filings/0000097134-25-000036.md) | not reported | [0.69](/filings/0000097134-26-000015.md) | [1.08](/filings/0000097134-26-000024.md) | [0.80](/filings/0000097134-25-000036.md) | not reported | [0.01](/filings/0000097134-26-000015.md) | [0.44](/filings/0000097134-26-000024.md) |
| Basic EPS | $ per share | [1.23](/filings/0000097134-24-000037.md) | not reported | [1.52](/filings/0000097134-25-000014.md) | [1.47](/filings/0000097134-25-000027.md) | [1.11](/filings/0000097134-25-000036.md) | not reported | [0.70](/filings/0000097134-26-000015.md) | [1.10](/filings/0000097134-26-000024.md) | [0.81](/filings/0000097134-25-000036.md) | not reported | [0.01](/filings/0000097134-26-000015.md) | [0.44](/filings/0000097134-26-000024.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [555](/filings/0000097134-23-000059.md) | [569](/filings/0000097134-25-000006.md) | [561](/filings/0000097134-24-000016.md) | [578](/filings/0000097134-24-000030.md) | [594](/filings/0000097134-24-000037.md) | [577](/filings/0000097134-26-000008.md) | [551](/filings/0000097134-25-000014.md) | [575](/filings/0000097134-25-000027.md) | [598](/filings/0000097134-25-000036.md) | [600](/filings/0000097134-26-000024.md) | [611](/filings/0000097134-26-000015.md) | [614](/filings/0000097134-26-000024.md) |
| Total assets | $m | [1,059](/filings/0000097134-23-000059.md) | [1,113](/filings/0000097134-25-000006.md) | [1,152](/filings/0000097134-24-000016.md) | [1,168](/filings/0000097134-24-000030.md) | [1,216](/filings/0000097134-24-000037.md) | [1,190](/filings/0000097134-26-000008.md) | [1,180](/filings/0000097134-25-000014.md) | [1,242](/filings/0000097134-25-000027.md) | [1,257](/filings/0000097134-25-000036.md) | [1,269](/filings/0000097134-26-000024.md) | [1,277](/filings/0000097134-26-000015.md) | [1,271](/filings/0000097134-26-000024.md) |
| Current liabilities | $m | [245](/filings/0000097134-23-000059.md) | [274](/filings/0000097134-25-000006.md) | [260](/filings/0000097134-24-000016.md) | [266](/filings/0000097134-24-000030.md) | [274](/filings/0000097134-24-000037.md) | [292](/filings/0000097134-26-000008.md) | [257](/filings/0000097134-25-000014.md) | [275](/filings/0000097134-25-000027.md) | [282](/filings/0000097134-25-000036.md) | [293](/filings/0000097134-26-000024.md) | [289](/filings/0000097134-26-000015.md) | [300](/filings/0000097134-26-000024.md) |
| Total liabilities | $m | [513](/filings/0000097134-23-000059.md) | [535](/filings/0000097134-25-000006.md) | [536](/filings/0000097134-24-000016.md) | [542](/filings/0000097134-24-000030.md) | [568](/filings/0000097134-24-000037.md) | [568](/filings/0000097134-26-000008.md) | [554](/filings/0000097134-25-000014.md) | [588](/filings/0000097134-25-000027.md) | [614](/filings/0000097134-25-000036.md) | [666](/filings/0000097134-26-000024.md) | [744](/filings/0000097134-26-000015.md) | [736](/filings/0000097134-26-000024.md) |
| Long-term debt | $m | not reported | [201](/filings/0000097134-24-000008.md) | not reported | not reported | not reported | [200](/filings/0000097134-25-000006.md) | not reported | not reported | not reported | [274](/filings/0000097134-26-000008.md) | not reported | not reported |
| Current portion of debt | $m | [5.9](/filings/0000097134-23-000059.md) | [6.4](/filings/0000097134-25-000006.md) | [7.2](/filings/0000097134-24-000016.md) | [7.8](/filings/0000097134-24-000030.md) | [0.6](/filings/0000097134-24-000037.md) | [1.3](/filings/0000097134-26-000008.md) | [0.5](/filings/0000097134-25-000014.md) | [0.4](/filings/0000097134-25-000027.md) | [0.4](/filings/0000097134-25-000036.md) | [0.4](/filings/0000097134-26-000024.md) | [0.4](/filings/0000097134-26-000015.md) | [0.5](/filings/0000097134-26-000024.md) |
| Shareholders' equity | $m | [545](/filings/0000097134-23-000059.md) | [577](/filings/0000097134-25-000006.md) | [615](/filings/0000097134-24-000016.md) | [625](/filings/0000097134-24-000030.md) | [647](/filings/0000097134-24-000037.md) | [621](/filings/0000097134-26-000008.md) | [624](/filings/0000097134-25-000014.md) | [652](/filings/0000097134-25-000027.md) | [641](/filings/0000097134-25-000036.md) | [602](/filings/0000097134-26-000024.md) | [531](/filings/0000097134-26-000015.md) | [533](/filings/0000097134-26-000024.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [54.4 d](/filings/0000097134-24-000037.md) | [63.8 d](/filings/0000097134-26-000008.md) | [2.9](/filings/0000097134-25-000014.md) | [18.6 d](/filings/0000097134-25-000027.md) | [30.7 d](/filings/0000097134-25-000036.md) | [37.5 d](/filings/0000097134-26-000008.md) | [(0.4)](/filings/0000097134-26-000015.md) | [22.5 d](/filings/0000097134-26-000024.md) | [28.7 d](/filings/0000097134-25-000036.md) | [14.2 d](/filings/0000097134-26-000008.md) | [(31.2)](/filings/0000097134-26-000015.md) | [5.0 d](/filings/0000097134-26-000024.md) |
| Capital expenditure | $m | [3.5 d](/filings/0000097134-24-000037.md) | [7.5 d](/filings/0000097134-26-000008.md) | [3.0](/filings/0000097134-25-000014.md) | [4.2 d](/filings/0000097134-25-000027.md) | [4.3 d](/filings/0000097134-25-000036.md) | [9.4 d](/filings/0000097134-26-000008.md) | [7.0](/filings/0000097134-26-000015.md) | [3.8 d](/filings/0000097134-26-000024.md) | [6.4 d](/filings/0000097134-25-000036.md) | [4.5 d](/filings/0000097134-26-000008.md) | [3.2](/filings/0000097134-26-000015.md) | [5.3 d](/filings/0000097134-26-000024.md) |
| Dividends paid | $m | [5.0 d](/filings/0000097134-24-000037.md) | [5.3 d](/filings/0000097134-26-000008.md) | [5.3](/filings/0000097134-25-000014.md) | [5.3 d](/filings/0000097134-25-000027.md) | [5.3 d](/filings/0000097134-25-000036.md) | [5.5 d](/filings/0000097134-26-000008.md) | [5.6](/filings/0000097134-26-000015.md) | [5.4 d](/filings/0000097134-26-000024.md) | [5.4 d](/filings/0000097134-25-000036.md) | [5.5 d](/filings/0000097134-26-000008.md) | [5.5](/filings/0000097134-26-000015.md) | [5.3 d](/filings/0000097134-26-000024.md) |
| Share repurchases | $m | [1.7 d](/filings/0000097134-24-000037.md) | [10.0 d](/filings/0000097134-26-000008.md) | [1.1](/filings/0000097134-25-000014.md) | [8.0 d](/filings/0000097134-25-000027.md) | [8.0 d](/filings/0000097134-25-000036.md) | [2.5 d](/filings/0000097134-26-000008.md) | [20.2](/filings/0000097134-26-000015.md) | [13.4 d](/filings/0000097134-26-000024.md) | [22.7 d](/filings/0000097134-25-000036.md) | [32.2 d](/filings/0000097134-26-000008.md) | [60.0](/filings/0000097134-26-000015.md) | [0.5 d](/filings/0000097134-26-000024.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.7](/filings/0000097134-23-000059.md) | [18.7](/filings/0000097134-24-000016.md) | [18.7](/filings/0000097134-24-000030.md) | [18.9](/filings/0000097134-24-000037.md) | [19.1](/filings/0000097134-25-000014.md) | [19.2](/filings/0000097134-25-000027.md) | [19.1](/filings/0000097134-25-000036.md) | [19.0](/filings/0000097134-26-000015.md) | [18.7](/filings/0000097134-26-000024.md) | [18.5](/filings/0000097134-25-000036.md) | [17.8](/filings/0000097134-26-000015.md) | [17.2](/filings/0000097134-26-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,049,303 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000097134-26-000024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.